Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corteva Inc. Common Stock (CTVA) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

Corteva Inc. Common StockTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

Corteva Inc. Common Stock vs Ginkgo Bioworks Holdings Inc — how do they compare? Corteva Inc. Common Stock trades at $13.75 (market cap $9.64B), while Ginkgo Bioworks Holdings Inc trades at $11.59 (market cap $772.39M). The key difference: Corteva Inc. Common Stock is far larger — about 12.5× Ginkgo Bioworks Holdings Inc's market cap, and Corteva Inc. Common Stock pays a 4.98% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Ginkgo Bioworks Holdings Inc for 7 Days on average.

CTVADNA
Market Cap
$9.64B$772.39M
Volume
41,241,2556,453,273
Sector
Basic MaterialsHealth
52-Week High
$90.51$15.83
52-Week Low
$11.92$5.48
Typical Hold Time
0 Days7 Days
Enterprise Value
$12.15B$874.34M
Dividend Yield
4.98%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Corteva Inc. Common Stock

No Aura AI signal available yet.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $11.47, down 7.57% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported a net loss of $312.76 million on $170.16 million revenue in 2025, with a high gross margin of 68.04% but negative net income margin. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting growth initiatives amid financial challenges.

The outlook remains speculative with significant cash burn and persistent losses, though partnerships and government contracts offer potential catalysts. Risks include high operating costs and reliance on funding, while analyst sentiment is divided equally between buy, hold, and sell ratings. Investment hinges on the company's ability to monetize its technology and achieve profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTVA
100% Buy0% Sell
Avg holding period · 0 Days
DNA
53% Buy47% Sell
Avg holding period · 7 Days

Top news

Latest headlines on both assets

About Corteva Inc. Common Stock

Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.

Read more on CTVA →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →